RU2018110617A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018110617A3 RU2018110617A3 RU2018110617A RU2018110617A RU2018110617A3 RU 2018110617 A3 RU2018110617 A3 RU 2018110617A3 RU 2018110617 A RU2018110617 A RU 2018110617A RU 2018110617 A RU2018110617 A RU 2018110617A RU 2018110617 A3 RU2018110617 A3 RU 2018110617A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPPCT/JP2015/074553 | 2015-08-29 | ||
| PCT/JP2015/074553 WO2017037813A1 (ja) | 2015-08-29 | 2015-08-29 | 塩基性薬物とソルビン酸とを含有する経皮吸収組成物 |
| PCT/JP2016/075203 WO2017038767A1 (ja) | 2015-08-29 | 2016-08-29 | 経皮吸収組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018110617A RU2018110617A (ru) | 2019-09-30 |
| RU2018110617A3 true RU2018110617A3 (https=) | 2019-09-30 |
| RU2702356C2 RU2702356C2 (ru) | 2019-10-08 |
Family
ID=58187853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018110617A RU2702356C2 (ru) | 2015-08-29 | 2016-08-29 | Композиция для чрескожного всасывания |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9974858B2 (https=) |
| EP (1) | EP3342423B1 (https=) |
| JP (2) | JP6259117B2 (https=) |
| KR (1) | KR20180039622A (https=) |
| CN (1) | CN107427509B (https=) |
| BR (1) | BR112018001387B8 (https=) |
| CO (1) | CO2018001831A2 (https=) |
| ES (1) | ES2864017T3 (https=) |
| MX (1) | MX388148B (https=) |
| MY (1) | MY189987A (https=) |
| PH (1) | PH12018500271A1 (https=) |
| RU (1) | RU2702356C2 (https=) |
| SG (1) | SG11201800043UA (https=) |
| UA (1) | UA123212C2 (https=) |
| WO (2) | WO2017037813A1 (https=) |
| ZA (1) | ZA201800296B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107427509B (zh) | 2015-08-29 | 2021-06-15 | 美德阿利克斯株式会社 | 含有碱性药物和山梨酸的经皮吸收组成物 |
| US11559519B2 (en) | 2018-01-31 | 2023-01-24 | Medrx, Co., Ltd. | Tizanidine therapy system |
| US11186585B2 (en) | 2018-08-17 | 2021-11-30 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
| TWI772807B (zh) * | 2019-05-27 | 2022-08-01 | 日商救急藥品工業股份有限公司 | 外用製劑 |
| CA3149152A1 (en) * | 2019-08-11 | 2021-02-18 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
| US12103639B2 (en) * | 2021-06-03 | 2024-10-01 | Sram, Llc | Bicycle control system |
| CA3226214A1 (en) * | 2021-08-30 | 2023-03-09 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid |
| US20240398765A1 (en) * | 2021-10-15 | 2024-12-05 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of tizanidine |
| CN116370439A (zh) * | 2022-04-01 | 2023-07-04 | 江苏山信药业有限公司 | 一种伐尼克兰透皮贴剂及其制备方法和其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61172830A (ja) * | 1985-01-26 | 1986-08-04 | Showa Denko Kk | 皮膚外用剤組成物 |
| DE60034458T2 (de) * | 1999-07-27 | 2008-01-03 | Hisamitsu Pharmaceutical Co., Inc., Tosu | Pflaster zur äusserlichen anwendung |
| US20040142024A1 (en) | 1999-07-27 | 2004-07-22 | Hisamitsu Pharmaceutical Co., Inc. | Patch formulation for external use |
| US20090130189A1 (en) * | 2004-03-19 | 2009-05-21 | Pfizer Health Ab | Means for transdermal administration of nicotine |
| JP4807974B2 (ja) * | 2005-06-30 | 2011-11-02 | 帝國製薬株式会社 | 経皮吸収促進組成物 |
| CN101032474B (zh) * | 2006-03-06 | 2011-02-16 | 重庆医药工业研究院有限责任公司 | 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法 |
| CN101143127A (zh) * | 2007-10-25 | 2008-03-19 | 复旦大学 | 一种酚妥拉明外用制剂及其制备方法 |
| AU2008327436B2 (en) * | 2007-11-22 | 2013-09-05 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| EP2255809B1 (en) * | 2008-02-27 | 2017-08-23 | Hisamitsu Pharmaceutical Co., Inc. | Medicated patch |
| EP2311498A4 (en) | 2008-08-05 | 2013-07-24 | Medrx Co Ltd | EXTERNAL PREPARATION COMPRISING A FATTY ACID SALT OR A BENZOIC ACID SALT OF A PHARMACOLOGICALLY ACTIVE BASIC COMPONENT, AND PROCESS FOR PRODUCTION THEREOF |
| JP2012158521A (ja) * | 2009-04-17 | 2012-08-23 | Kureha Corp | 外用剤 |
| EP2476414B1 (en) * | 2009-09-07 | 2015-03-04 | NIPRO Patch Co., Ltd. | Transdermally absorbable preparation |
| RU2013102263A (ru) * | 2010-06-18 | 2014-07-27 | Мерц Фарма Гмбх Унд Ко. Кгаа | Гелевые лекарственные формы для местного применения производных 1-аминоалкилциклогексана |
| HUE045479T2 (hu) * | 2012-06-20 | 2019-12-30 | Medrx Co Ltd | Tapadó preparátum készítmény, amely elõállítható gyógyszerhatóanyag, szerves oldószer, lipofil kenõcsalap és por összekeverésével |
| JP2014125483A (ja) | 2012-12-27 | 2014-07-07 | Lion Corp | 貼付剤 |
| CN107427509B (zh) * | 2015-08-29 | 2021-06-15 | 美德阿利克斯株式会社 | 含有碱性药物和山梨酸的经皮吸收组成物 |
-
2015
- 2015-08-29 CN CN201580078659.1A patent/CN107427509B/zh active Active
- 2015-08-29 WO PCT/JP2015/074553 patent/WO2017037813A1/ja not_active Ceased
-
2016
- 2016-08-29 RU RU2018110617A patent/RU2702356C2/ru active
- 2016-08-29 MX MX2018002015A patent/MX388148B/es unknown
- 2016-08-29 WO PCT/JP2016/075203 patent/WO2017038767A1/ja not_active Ceased
- 2016-08-29 SG SG11201800043UA patent/SG11201800043UA/en unknown
- 2016-08-29 ES ES16841799T patent/ES2864017T3/es active Active
- 2016-08-29 MY MYPI2018700724A patent/MY189987A/en unknown
- 2016-08-29 UA UAA201803201A patent/UA123212C2/uk unknown
- 2016-08-29 KR KR1020187001366A patent/KR20180039622A/ko not_active Withdrawn
- 2016-08-29 EP EP16841799.6A patent/EP3342423B1/en active Active
- 2016-08-29 BR BR112018001387A patent/BR112018001387B8/pt active IP Right Grant
- 2016-08-29 JP JP2016558808A patent/JP6259117B2/ja active Active
- 2016-09-28 US US15/279,210 patent/US9974858B2/en active Active
-
2017
- 2017-06-08 JP JP2017113200A patent/JP2017149782A/ja active Pending
-
2018
- 2018-01-16 ZA ZA2018/00296A patent/ZA201800296B/en unknown
- 2018-02-06 PH PH12018500271A patent/PH12018500271A1/en unknown
- 2018-02-22 CO CONC2018/0001831A patent/CO2018001831A2/es unknown
- 2018-04-23 US US15/960,392 patent/US10588973B2/en active Active
-
2020
- 2020-02-05 US US16/782,988 patent/US11382978B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2702356C2 (ru) | 2019-10-08 |
| BR112018001387A2 (pt) | 2018-09-11 |
| SG11201800043UA (en) | 2018-02-27 |
| EP3342423B1 (en) | 2021-03-10 |
| US20180236082A1 (en) | 2018-08-23 |
| EP3342423A4 (en) | 2018-07-25 |
| PH12018500271A1 (en) | 2018-08-13 |
| BR112018001387B1 (pt) | 2023-09-05 |
| US20200171156A1 (en) | 2020-06-04 |
| ZA201800296B (en) | 2019-04-24 |
| US20170056502A1 (en) | 2017-03-02 |
| KR20180039622A (ko) | 2018-04-18 |
| JPWO2017038767A1 (ja) | 2017-09-07 |
| CN107427509A (zh) | 2017-12-01 |
| MX388148B (es) | 2025-03-19 |
| CO2018001831A2 (es) | 2018-05-21 |
| BR112018001387B8 (pt) | 2024-03-05 |
| ES2864017T3 (es) | 2021-10-13 |
| EP3342423A1 (en) | 2018-07-04 |
| WO2017038767A1 (ja) | 2017-03-09 |
| US9974858B2 (en) | 2018-05-22 |
| MY189987A (en) | 2022-03-22 |
| US10588973B2 (en) | 2020-03-17 |
| US11382978B2 (en) | 2022-07-12 |
| WO2017037813A1 (ja) | 2017-03-09 |
| UA123212C2 (uk) | 2021-03-03 |
| MX2018002015A (es) | 2018-06-19 |
| JP2017149782A (ja) | 2017-08-31 |
| RU2018110617A (ru) | 2019-09-30 |
| JP6259117B2 (ja) | 2018-01-10 |
| CN107427509B (zh) | 2021-06-15 |